Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
AVITA Medical, Inc. has 3 disclosed suppliers and 2 disclosed customers, each named in an SEC filing with the sentence that discloses it.
High 10.62 at 2:30 pm ET, low 10.16 at 10:15 am ET.
AVITA Medical, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Between 2015 and December 31, 2025, we have received an aggregate total of $40.7 million in payments under the contract with BARDA.”
FILING10-K0001193125-26-049031cik 0001762303
“Regenity manufactures and supplies Cohealyx , an AVITA Medical-branded, FDA-cleared, collagen-based dermal matrix.”
FILING10-K0001193125-26-049031cik 0001762303
“In addition, in the United States, we hold the rights to manufacture and exclusively market, sell, and distribute PermeaDerm ® , a biosynthetic wound matrix, under the terms of exclusive multi-year distribution and contract manufacturing agreements with Stedical Scientific, Inc. ("Stedical").”
FILING10-K0001193125-26-049031cik 0001762303
“In January 2024, we entered into an exclusive multi-year distribution agreement with Stedical Scientific, Inc. ("Stedical") to market, sell, and distribute PermeaDerm, a biosynthetic wound matrix in the United States ("U.S.").”
FILING10-K0001193125-26-049031cik 0001762303
“In July 2024, we entered into an exclusive multi-year development and distribution agreement with Collagen Matrix, LLC d/b/a as Regenity Biosciences ("Regenity"), granting us exclusive rights to market, sell, and distribute Cohealyx, an AVITA-medical branded collagen-based dermal matrix in the U.S., with potential expansion into the European Union ("E.U."), Australia, and Japan.”
FILING10-K0001193125-26-049031cik 0001762303
Watchlist prices, news filtered to it, and its next report on your desk.
RCEL (AVITA Medical, Inc.) has 3 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.